Study Results for Nivolumab and Pembrolizumab in Head and Neck Cancer

February 20, 2017
Everett Vokes, MD

Everett Vokes, MD, John E. Ultmann professor of Medicine and Radiation Oncology, physician-in-chief, University of Chicago Medical Center, chair, Department of Medicine, University of Chicago Medicine, discusses results of studies that investigated nivolumab and pembrolizumab in head and neck cancer.